Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from abacavir-based therapy to tenofovir-based therapy and arterial tonometry in adults with HIV
ACTRN12609000014257Phase 4Completed
- Sponsor
- St. Vincent's University Hospital
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine + tenofovir disoproxil and tenofovir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by St. Vincent's University Hospital. Primary endpoint: Cardiovascular function by radial artery applanation tonometry at week 24. Started Sep 2008; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxiltenofovir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12609000014257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000014257.